Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways

Tine Cuppens, Matthieu Moisse, Jeroen Depreeuw, Daniela Annibali, Eva Colas, Antonio Gil-Moreno, Jutta Huvila, Olli Carpen, Michal Zikan, Xavier Matias-Guiu, Philippe Moerman, Sabrina Croce, Diether Lambrechts, Frederic Amant

Research output: Contribution to journalArticleScientificpeer-review

Original languageEnglish
JournalInternational Journal of Cancer
Volume142
Issue number6
Pages (from-to)1230-1243
Number of pages14
ISSN0020-7136
DOIs
Publication statusPublished - 15 Mar 2018
MoE publication typeA1 Journal article-refereed

Fields of Science

  • uterine leiomyosarcoma
  • molecular profiling
  • RNA sequencing
  • copy number alteration
  • data integration
  • SOFT-TISSUE SARCOMA
  • MOLECULAR SUBTYPES
  • TUMOR PROGRESSION
  • CANCER GENOMES
  • INHIBITION
  • EXPRESSION
  • VARIANTS
  • IMPACT
  • DOXORUBICIN
  • CARCINOMA
  • 3122 Cancers

Cite this

Cuppens, T., Moisse, M., Depreeuw, J., Annibali, D., Colas, E., Gil-Moreno, A., Huvila, J., Carpen, O., Zikan, M., Matias-Guiu, X., Moerman, P., Croce, S., Lambrechts, D., & Amant, F. (2018). Integrated genome analysis of uterine leiomyosarcoma to identify novel driver genes and targetable pathways. International Journal of Cancer, 142(6), 1230-1243. https://doi.org/10.1002/ijc.31129